Efficacy and Safety of Tapentadol Extended Release Compared with Oxycodone Controlled Release for the Management of Moderate to Severe Chronic Pain Related to Osteoarthritis of the Knee-Reference-Cited by-同舟云学术

Efficacy and Safety of Tapentadol Extended Release Compared with Oxycodone Controlled Release for the Management of Moderate to Severe Chronic Pain Related to Osteoarthritis of the Knee

Published:2010-08 Issue:8 Volume:30 Page:489-505
ISSN:1173-2563
Container-title:Clinical Drug Investigation
language:en
Short-container-title:Clinical Drug Investigation

Author:

Afilalo Marc,Etropolski Mila S.,Kuperwasser Brigitte,Kelly Kathy,Okamoto Akiko,Van Hove Ilse,Steup Achim,Lange Bernd,Rauschkolb Christine,Haeussler Juergen

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),General Medicine

Reference41 articles.

1. Epidemiology of osteoarthritis: Prevalence, risk factors and functional impact

2. Osteoarthritis--the impact of a serious disease

3. OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines

4. Osteoarthritis

5. Chronic Pain of Osteoarthritis: Considerations for Selecting an Extended-Release Opioid Analgesic

Cited by 186 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

2. Adverse Effects of Opioid Analgesics in Osteoarthritis Treatment: A Global Meta-Analysis, 2000-2022;CHINA CDC WEEKLY;2024

3. Cannabis for medical use versus opioids for chronic non-cancer pain: a systematic review and network meta-analysis of randomised clinical trials;BMJ Open;2024-01

4. Tapentadol, an opioid as a strategy for the treatment of chronic pain? A narrative review;Journal of Pharmaceutical and Biological Sciences;2023-07-15

5. Considerations for perioperative opioid analgesic stewardship in Australia: a focus on tapentadol;Pain Management;2023-05